Evidence map›Paper›PMID 29507414›Full record

ArticleNature neuroscience2018

Single-cell mass cytometry reveals distinct populations of brain myeloid cells in mouse neuroinflammation and neurodegeneration models.

Bahareh Ajami, Nikolay Samusik, Peter Wieghofer, Peggy P Ho, Andrea Crotti, Zach Bjornson, Marco Prinz, Wendy J Fantl, Garry P Nolan, Lawrence Steinman

Open access · greenAbstract read
In one paragraph

Article in Nature neuroscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 211 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
211citing papers in PubMed, 1 pooled it
20.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

211 citing papers in PubMed, 1 synthesis or guideline pooled it, 338 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Alkaloids from In Vitro CulturedPlants (Basel, Switzerland) · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

151 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Bahareh AjamiDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA. b.ajami@stanford.edu.ORCID http://orcid.org/0000-0003-0320-4677
Nikolay SamusikBaxter Laboratory in Stem Cell Biology, Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA.
Peter WieghoferInstitute of Neuropathology, Medical Faculty, University of Freiburg, Freiburg, Germany.
Peggy P HoDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA.
Andrea CrottiDepartment of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA, USA.
Zach BjornsonBaxter Laboratory in Stem Cell Biology, Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA.
Marco PrinzInstitute of Neuropathology, Medical Faculty, University of Freiburg, Freiburg, Germany.
Wendy J FantlBaxter Laboratory in Stem Cell Biology, Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA.
Garry P NolanBaxter Laboratory in Stem Cell Biology, Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA.
Lawrence SteinmanDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA. steinman@stanford.edu.
Stanford University · USUniversity of Freiburg · DEStanford Medicine · USUniversity of California San Diego · US

Funding

Using a tonsil organoid system to probe conditions for the induction of protective antibody and T cell responses to influenza.U19AI057229 · NIAID · STANFORD UNIVERSITY · PI Mark Morris Davis · 2003 to 2026
$88.5M
Systems Biology CoreU19AI100627 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI ULEVITCH, RICHARD J · 2012 to 2021
$49.1M
Supplement to Enhance Wellness and Resiliency in the Graduate EnvironmentT32GM007276 · NIGMS · STANFORD UNIVERSITY · PI MORRISON, ASHBY J. · 1985 to 2023
$32.9M
Balanced signaling cues to guide cell transitions in the blood lineage continuumR01HL120724 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHAKRABORTY, ARUP K., NOLAN, GARRY P · 2015 to 2019
$3.7M
Stanford Technology Accelerating Medicines Partnership CenterUH2AR067676 · NIAMS · STANFORD UNIVERSITY · PI ROBINSON, WILLIAM H, UTZ, PAUL JOSEPH · 2014 to 2020
$2.6M
(PQD2)New Biomarkers and Pathways to Enhance Cure in Ovarian CancersR01CA184968 · NCI · STANFORD UNIVERSITY · PI FANTL, WENDY JANE, SIKIC, BRANIMIR I · 2014 to 2017
$2.0M
Highly multiplexed ion-beam tissue molecular imaging with sub-micron resolutionR33CA183654 · NCI · STANFORD UNIVERSITY · PI NOLAN, GARRY P · 2014 to 2016
$1.2M
Integrating mass cytometric and transcriptomic profiles of solid tumorsR33CA183692 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WEISS, WILLIAM A · 2014 to 2016
$1.2M
Highly multiplexed ion-beam tissue RNA in situ imaging with sub-micron resolutionR21CA183660 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BOROWSKY, ALEXANDER D, LEVENSON, RICHARD M. · 2014 to 2015
$539k
NCI NIH HHS R01 CA184968NCI NIH HHS R21 CA183660NCI NIH HHS R33 CA183654NCI NIH HHS R33 CA183692NHLBI NIH HHS R01 HL120724NIAID NIH HHS U19 AI057229NIAID NIH HHS U19 AI100627NIAMS NIH HHS UH2 AR067676NIGMS NIH HHS T32 GM007276
6 · The paper itself

Abstract

Neuroinflammation and neurodegeneration may represent two poles of brain pathology. Brain myeloid cells, particularly microglia, play key roles in these conditions. We employed single-cell mass cytometry (CyTOF) to compare myeloid cell populations in the experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis, the R6/2 model of Huntington's disease (HD) and the mutant superoxide dismutase 1 (mSOD1) model of amyotrophic lateral sclerosis (ALS). We identified three myeloid cell populations exclusive to the CNS and present in each disease model. Blood-derived monocytes comprised five populations and migrated to the brain in EAE, but not in HD and ALS models. Single-cell analysis resolved differences in signaling and cytokine production within similar myeloid populations in EAE compared to HD and ALS models. Moreover, these analyses highlighted α5 integrin on myeloid cells as a potential therapeutic target for neuroinflammation. Together, these findings illustrate how neuropathology may differ between inflammatory and degenerative brain disease.

Indexed as

Amyotrophic Lateral SclerosisAnimalsBrainCREB-Binding ProteinCX3C Chemokine Receptor 1CytokinesDisease Models, AnimalEncephalomyelitis, Autoimmune, ExperimentalHuntingtin ProteinHuntington DiseaseIntracellular Signaling Peptides and ProteinsLuminescent ProteinsMiceMice, Inbred C57BLMice, Mutant StrainsMice, TransgenicCREB-Binding ProteinCX3C Chemokine Receptor 1Cx3cr1 protein, mouseCytokinesHtt protein, mouseHuntingtin ProteinIntracellular Signaling Peptides and ProteinsLuminescent ProteinsSuperoxide Dismutase-1

Identifiers

PMID29507414
PMCPMC8629134
OpenAlexW2791954023

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.